Literature DB >> 15584486

The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients.

Darcy Cox1, Daniel Pelletier, Claude Genain, Sharmila Majumdar, Ying Lu, Sarah Nelson, David C Mohr.   

Abstract

OBJECTIVE: The purpose of this study was to examine the relationships between cognitive functioning, whole brain magnetic transfer ratio (MTR) imaging, supratentorial 1H-magnetic resonance spectroscopy imaging (1HMRSI), and conventional T1 and T2 imaging in a homogenous sample of SPMS patients.
METHODS: Nineteen patients underwent a single 90-min imaging session that obtained T1-and T2-weighted images and MTR. 1HMRSI was obtained on 14 of these patients. Patients underwent a neuropsychological battery, which was used to create an integrated measure of cognitive impairment. Cognitive impairment was the dependent variable in two hierarchical multiple regression analyses in which T2 lesion load, T1 lesion load, and MTR or NAA/Cr were entered sequentially.
RESULTS: MTR was significantly related to cognitive functioning (deltaR2 = 0.22, P = 0.02) after accounting for T2 lesion load (deltaR2 = 0.33, P = 0.01) and T1 lesion load (deltaR2 = 0.00, P = 0.98). NAA/Cr was not significantly related to cognitive functioning.
CONCLUSIONS: Cognitive dysfunction may act as a clinical marker of normal appearing brain tissue pathology in multiple sclerosis.

Entities:  

Mesh:

Year:  2004        PMID: 15584486     DOI: 10.1191/1352458504ms1095oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

Review 1.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 2.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

3.  MRI predictors of cognitive outcome in early multiple sclerosis.

Authors:  M S A Deloire; A Ruet; D Hamel; M Bonnet; V Dousset; B Brochet
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

4.  Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

Authors:  James M Stankiewicz; Bonnie I Glanz; Brian C Healy; Ashish Arora; Mohit Neema; Ralph H B Benedict; Zachary D Guss; Shahamat Tauhid; Guy J Buckle; Maria K Houtchens; Samia J Khoury; Howard L Weiner; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

Review 5.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

6.  Corpus callosum microstructural changes correlate with cognitive dysfunction in early stages of relapsing-remitting multiple sclerosis: axial and radial diffusivities approach.

Authors:  Carolina de Medeiros Rimkus; Thiago de Faria Junqueira; Katarina Paz Lyra; Marcel P Jackowski; Melissa A R Machado; Eliane C Miotto; Dagoberto Callegaro; Maria Concepción García Otaduy; Claudia da Costa Leite
Journal:  Mult Scler Int       Date:  2011-07-10

7.  Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.

Authors:  Daniela Pinter; Michael Khalil; Alexander Pichler; Christian Langkammer; Stefan Ropele; Peter B Marschik; Siegrid Fuchs; Franz Fazekas; Christian Enzinger
Journal:  Neuroimage Clin       Date:  2015-03-05       Impact factor: 4.881

Review 8.  Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker.

Authors:  Kelley M Swanberg; Karl Landheer; David Pitt; Christoph Juchem
Journal:  Front Neurol       Date:  2019-11-15       Impact factor: 4.003

Review 9.  Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.

Authors:  Tanuja Chitnis; Jo Vandercappellen; Miriam King; Giampaolo Brichetto
Journal:  Neurol Ther       Date:  2022-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.